Advertisements

Тетрациклин

Quick links to important sections

Тетрациклин

Selected form

Advertisements

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Тетрациклин

What is Тетрациклин? (Tetracycline)

Property Description
Active ingredient Tetracycline Hydrochloride
Form Capsules, Tablets, Ointment (Topical/Ophthalmic)
Pharmacological class Antibiotic (Tetracycline class)
Common use Systemic and topical bacterial infections
Origin Natural (originally derived from Streptomyces bacteria)
Status Prescription-only (Rx)

Classification and Recognized Use of Tetracycline

Тетрациклин (Tetracycline) is a prescription-only drug that is the name-sake and first-generation member of the tetracycline class of broad-spectrum antibiotics. Its primary purpose is to manage and treat a wide variety of bacterial infections by halting the growth and spread of susceptible organisms. This agent is clinically recognized for its efficacy against infections caused by specific intracellular pathogens, such as Chlamydia and Rickettsia species. This means the drug remains an important treatment option when other antibiotic classes are less effective against these unique types of germs. Pharmacologically, it is designated as an antiinfective agent that exerts a bacteriostatic action, functioning as a protein synthesis inhibitor to suppress microbial reproduction.


Composition and Unique Origin

The active compound in the medicine is Tetracycline, most often formulated as Tetracycline Hydrochloride. Тетрациклин holds a unique place in medical history as it is a compound of natural origin, having originally been isolated from the Streptomyces genus of bacteria. This differs from many newer drugs that are entirely synthetic. The substance is chemically classified as a polycyclic naphthacene carboxamide derivative, which is the core structure responsible for its antibacterial mechanism. While the base compound is generic, it is available under various brand names globally, such as Achromycin V and Sumycin, often manufactured as simple, single-ingredient products.


Available Forms and Administration Types

Тетрациклин is available primarily in two main dosage forms for patient use: capsules or tablets for oral administration, and ointment for topical administration. The oral forms deliver the drug systemically (internally) and contain the active ingredient alongside inert fillers. Topical formulations, conversely, use a petroleum-based vehicle to provide a direct, localized antibacterial benefit to sites like the skin or eye. This differentiation in form allows the medicine to be precisely targeted either against deep-seated systemic infections or surface-level microbial activity, ensuring flexibility in its application.

Advertisements

What side effects are possible with Тетрациклин?

Possible side effects and safety information

The safety profile of Tetracycline is structured around its documented adverse reactions across several major system-organ classes, as classified in official regulatory sources.

Adverse Reaction Scope

The most frequently observed effects generally involve the Gastrointestinal System, leading to issues such as nausea, vomiting, and diarrhea. Additionally, reactions affecting the Skin and Subcutaneous Tissue are common, including maculopapular and erythematous rashes, and a specific risk of photosensitivity (an exaggerated reaction to sunlight).

System-Organ Class Examples of Documented Effects
Gastrointestinal Disorders Nausea, vomiting, diarrhea, stomatitis, esophagitis
Skin Disorders Rash, photosensitivity, exfoliative dermatitis (rare)
Nervous System Disorders Headache, benign intracranial hypertension
Hepatobiliary Disorders Liver enzyme elevation, hepatic toxicity

Serious Adverse Reactions and Population Constraints

Several serious adverse reactions are documented in regulatory labeling. These include Benign Intracranial Hypertension (Pseudotumor Cerebri), which can potentially affect vision, and the risk of Severe Hepatotoxicity, particularly in patients with pre-existing renal impairment. Another significant safety pattern is the risk of Clostridium difficile-Associated Diarrhea (CDAD), which may occur during or after treatment.

The use of systemic Tetracycline is contraindicated in specific patient groups due to irreversible safety risks. Children under eight years of age and pregnant or lactating patients must avoid the drug due to the established risk of permanent discoloration of teeth and inhibition of bone growth. Prolonged use of the medicine is associated with the potential for superinfections caused by the overgrowth of non-susceptible organisms, such as Candida.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Suspected Tetracycline overdose requires immediate emergency medical attention. Official labeling mandates that if an individual has collapsed, experienced a seizure, has trouble breathing, or cannot be awakened, emergency services must be contacted immediately, or a Poison Control center should be called.

Documented Overdose Manifestations

The regulatory profile documents acute symptoms including anorexia, nausea, vomiting, and diarrhea. Severe manifestations center on organ and neurological toxicity. The primary neurological concern is benign intracranial hypertension (pseudotumor cerebri), presenting with signs such as headache and visual disturbances (e.g., blurred vision). In infants, a specific sign of toxicity is the presence of bulging fontanels.

Severe Outcomes and Required Actions

Overdose is associated with the potential for fatal liver failure (hepatotoxicity) and dose-related nephrotoxicity, often indicated by a rise in BUN. Patients with pre-existing renal or hepatic impairment are officially noted as being at risk for excessive systemic accumulation and increased toxicity.

Since no specific antidote is known, management focuses on supportive measures. Officially described procedures include performing gastric lavage promptly and instituting symptomatic treatment, with a requirement to maintain a high fluid intake. The drug must be discontinued if signs of increased intracranial pressure develop.

Advertisements

Therapeutic Uses of Тетрациклин

Tetracycline (Тетрациклин) is commonly used to help manage a wide spectrum of bacterial infections and is considered relevant for easing specific symptomatic clusters, which supports the patient when infection-driven symptoms become more noticeable. This medication is applied in addressing numerous conditions that involve inflammatory or irritative processes.

The primary therapeutic areas include targeting atypical and systemic infections like rickettsial diseases, certain respiratory infections, and infections caused by Chlamydia. It is also used for relief for inflammatory skin manifestations such as moderate-to-severe acne, and as an alternative support for penicillin-allergic patients needing treatment for infections like syphilis.

This medication is generally applied in conditions marked by heightened, systemic symptoms or pronounced skin lesions. It is relevant in situations where symptoms cluster into patterns of high fever, body aches, and general malaise, or severe inflammation.

“Tetracycline helps address symptom clusters that may become intense or disruptive, supporting the patient during difficult episodes.”

Quick Fact: Relief for Inflammatory Symptoms Tetracycline may assist with easing the discomfort and visible severity of infectious and inflammatory symptoms, supporting day-to-day comfort.

Advertisements

Eligibility and Restrictions for Use

Eligibility Scope

Category Eligibility Rule
Populations for whom use is allowed: Adults and children ge 8 years of age.
Populations for whom use is contraindicated: Individuals with hypersensitivity to any tetracycline; pregnant individuals (last half); children under 8 years; nursing individuals.

Age and Condition-Specific Eligibility Rules

  • Age: Use is contraindicated in children under 8 years because the period of tooth development carries a risk of permanent discoloration and enamel hypoplasia. The drug is reserved for adults and children 8 years and older.
  • Reproductive Status: Tetracycline is contraindicated in the last half of pregnancy as it crosses the placenta and can affect fetal skeletal and dental development. Use while breastfeeding is not recommended by the manufacturer.
  • Organ Function: Severe renal impairment and chronic hepatic impairment are typically contraindicated conditions. This restriction is due to the risk of excessive systemic accumulation, which can lead to complications like azotemia and hyperphosphatemia.
  • Comorbidities: Use is contraindicated for patients with Systemic Lupus Erythematosus (due to risk of exacerbation) and for those concurrently using systemic retinoids or the anesthetic Methoxyflurane.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Tetracycline is known to interact with several medicinal products and substance categories, primarily through two main mechanisms: chelation and interference with other drug effects.

Absorption Interference

The most common interaction involves the chelation of tetracycline by products containing multivalent metal cations, such as aluminum, calcium, magnesium, iron, zinc, and bismuth. These cations form insoluble complexes with the antibiotic in the gastrointestinal tract, significantly reducing its absorption and potentially leading to treatment failure. This includes common products like antacids, laxatives, and iron or multivitamin supplements. To mitigate this interaction, it is generally recommended to separate the administration of tetracycline and any cation-containing product by at least two hours.

Pharmacodynamic and Pharmacokinetic Interactions

Use of tetracycline with certain medicines is restricted due to heightened risk of severe adverse effects. The combination with oral retinoids (like acitretin or tretinoin) is typically avoided as both classes can independently increase the risk of pseudotumor cerebri (increased pressure in the brain). Concurrent use with the anesthetic methoxyflurane is also restricted due to the potential for fatal kidney and liver toxicity. When administered with anticoagulants like warfarin, tetracycline may increase their effect, necessitating close and frequent monitoring of blood coagulation parameters (INR). Additionally, tetracycline's bacteriostatic action may interfere with the bactericidal effect of penicillin-class antibiotics, and concurrent use is generally discouraged.

Advertisements

Mechanism of Action

The mechanism of action of Tetracycline (Тетрациклин) centers on the inhibition of essential bacterial protein synthesis. The molecule enters susceptible bacterial cells and specifically binds to the 30S ribosomal subunit. This interaction physically blocks the ribosomal binding site, preventing the aminoacyl-tRNA from attaching to the A-site. The resulting blockade immediately arrests the elongation phase of translation, halting the assembly of polypeptide chains. This molecular interference prevents the bacteria from synthesizing the structural and enzymatic proteins necessary for growth and replication. The primary system-level physiological consequence is a bacteriostatic effect, meaning the proliferation of the bacterial population is stopped, allowing the host's immune system to clear the non-dividing cells. However, this mechanism is constrained by bacterial counter-mechanisms, including the activation of efflux pumps that expel the drug or ribosomal protection proteins that sterically hinder binding, thereby reducing the drug's physiological effect.

Advertisements

Dosage and Administration Information

How to Use Tetracycline

The administration of Tetracycline (Tetracycline Hydrochloride) follows prescribed guidelines, focusing on the oral route for systemic treatment. The standard adult regimen is typically 1 gram daily, divided into either 500 mg doses every 12 hours or 250 mg doses every 6 hours. Dosing may be increased to 500 mg four times a day for severe infections, while lower, 125 mg to 500 mg daily doses may be used for maintenance, such as in the management of acne.


Official Administration Conditions

Proper use requires strict adherence to timing and physical constraints to ensure optimal absorption:

  • Timing with Meals: The medicine must be taken on an empty stomach—specifically, 1 hour before or 2 hours after any food or dairy products, as these significantly impair absorption.
  • Fluid and Posture: Each dose must be swallowed with adequate fluid (water) while the patient is standing or sitting upright. Taking the dose immediately before going to bed must be avoided to mitigate esophageal irritation.

Usage Patterns and Duration

Treatment duration is specific to the condition, requiring completion even after symptoms subside. For infections caused by Streptococcus, therapy must continue for at least 10 days. Uncomplicated infections, like those caused by Chlamydia, generally require a minimum of 7 days. Long-term use for skin conditions such as acne can extend for at least three months.


Population and Procedural Rules

Age and dose adjustment rules are established for specific patient groups. The drug is contraindicated for use in children under 8 years of age. For older children, dosing is based on body weight (25 to 50 mg/kg/day) divided into four equal doses. For patients with renal impairment, the total dosage must be decreased by either reducing the individual dose amount or extending the time interval between doses to prevent drug accumulation.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Tetracycline (Тетрациклин)


Evidence for Use in Rickettsial and Atypical Systemic Infections

Research exploring tetracycline's use in patients with certain serious systemic infections, such as those caused by Rickettsia (including types of typhus and spotted fever), typically involves both Randomized Controlled Trials (RCTs) and observational cohort studies. Outcomes that were observed included the time until fever subsided and overall tracking of survival rates. The research describes patterns observed that studies conducted during periods of increased symptom activity reported measurements of changes in clinical status during the acute phase of the illness.

What remains unclear is the direct applicability of all this evidence to the original tetracycline compound today. The certainty remains low for direct comparisons with modern agents. The evidence level is generally described as High for the tetracycline class overall, though Moderate specifically for the original compound because older trials may have methodological limitations.


Evidence for Use in Inflammatory Skin Conditions (Acne Vulgaris)

For inflammatory skin conditions like moderate-to-severe acne, research examined the use of tetracycline in conditions characterized by fluctuating or episodic manifestations. The evidence landscape includes RCTs, where tetracycline was studied alongside other therapies or placebo, and Systematic Reviews. These studies monitored outcomes linked to inflammatory states, such as counting the change in the number of inflammatory and non-inflammatory skin lesions.

What remains uncertain is the long-term data for patients stopping the treatment, as follow-up durations were limited in many trials. Furthermore, the concern over bacterial resistance (specifically in C. acnes) is a documented factor that may affect future research outcomes.


What Is Still Uncertain About Tetracycline Research

The certainty remains low regarding direct comparisons between the original tetracycline compound and the newer, modified antibiotics used today. Much of the evidence supporting the drug's initial registration is historical, and its quality varies across studies when assessed by modern standards. Specific research gaps include limited information for long-term outcomes and a lack of sufficient data for certain subgroups, such as older adults or those with multiple coexisting health conditions. The documented rise in antimicrobial resistance is a critical, ongoing factor that affects the interpretation of all past and current evidence.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Тетрациклин (FAQ)

Q: Why is Тетрациклин not used to treat the common cold or flu?

Tetracycline is classified as an antibiotic, meaning its function is to target and suppress the growth of susceptible bacteria. Official product information indicates the medication is not effective against viral pathogens, such as those that cause the common cold or influenza (flu). Therefore, it is not prescribed for these types of viral conditions.

Q: Does Тетрациклин interact with over-the-counter pain relievers like acetaminophen or ibuprofen?

Regulatory information suggests there is typically no direct medicinal interaction between Tetracycline and Acetaminophen. However, both medications can place a potential burden on the liver, and caution is warranted. The concurrent use of any drug that carries a potential hepatic risk is typically reviewed by a healthcare provider.

Q: Can Тетрациклин affect the effectiveness of hormonal birth control pills or patches?

General regulatory guidance suggests that Tetracycline does not typically reduce the effectiveness of hormonal contraceptives. The main concern is related to absorption: if the medication causes severe gastrointestinal side effects, such as repeated vomiting or persistent diarrhea, the absorption of oral birth control pills could potentially be compromised.

Q: Are there any known interactions between Тетрациклин and alcohol consumption?

Official documentation states that the specific interaction between Tetracycline and alcohol is generally unknown. In general, alcohol consumption may hinder the body's natural ability to fight infection and support recovery, which is why it is often avoided while on antibiotic therapy.

Q: Is 'black hairy tongue' a reported side effect of Тетрациклин, and is it a serious concern?

Yes, official documents confirm that black or hairy tongue (known medically as lingua villosa nigra) is a documented, though rare, possible side effect of the medication. This effect is generally considered self-limiting, meaning it typically resolves on its own once the medicine is stopped.

Q: Why is Tетрациклин sometimes used as an alternative treatment for people allergic to penicillin?

Tetracycline is clinically recognized as an alternative treatment option for patients who have a confirmed allergy to penicillin-class antibiotics. It is effective against specific susceptible infections, such as those caused by Rickettsia or Chlamydia species, where penicillin is not the primary choice or is contraindicated.

Q: What are the official recommendations about what to do after missing a dose of Тетрациклин?

According to official prescribing information, if a single dose is missed, patients are advised to take it as soon as it is remembered. However, if it is nearly time for the next scheduled dose, the missed dose is typically skipped entirely. It is generally advised that a double dose not be taken to attempt to make up for the missed one.

Q: Is there any research on the use of Тетрациклин for malaria prevention or treatment?

While not the primary purpose, research has examined the tetracycline class of antibiotics and confirmed they exhibit antimalarial effects. This effect is due to the drug class's ability to interfere with an essential structure within the Plasmodium parasite, which is responsible for causing malaria.

Q: What is meant by the drug's 'anti-anabolic effect' as described in some research?

The drug's primary mechanism of action is to act as a protein synthesis inhibitor within bacterial cells, effectively stopping them from growing and replicating. This molecular action of suppressing the creation of new cellular material is the biological function often referred to in research as an 'anti-anabolic effect'.

Q: Does taking Тетрациклин make people feel dizzy or lightheaded?

Dizziness and feeling lightheaded are documented adverse effects that may be reported by patients taking the medicine. Regulatory documents specify that these symptoms may also be signs of a rare, serious condition known as increased pressure around the brain (intracranial hypertension).

Q: Is Тетрациклин effective against infections spread by ticks, like Lyme disease or Rocky Mountain spotted fever?

Official documents confirm that Tetracycline is indicated for infections caused by Rickettsial species, which include conditions like Rocky Mountain Spotted Fever. The broader class of tetracycline antibiotics is also used as part of the treatment for certain tick-borne infections, such as Lyme disease.

Q: What is the risk of permanent tooth discoloration from Тетрациклин in adults?

The risk of permanent tooth discoloration is strictly linked to drug exposure during the active period of tooth development. This is why the drug is specifically contraindicated for children under 8 years of age and during the last half of pregnancy, as their teeth are still forming.

Q: What is the rare side effect of increased pressure around the brain, and what are its signs?

The condition is formally known as Benign Intracranial Hypertension, or Pseudotumor Cerebri. The documented signs associated with this serious condition include the onset of a severe headache, nausea and vomiting, and concerning changes in vision.

Q: What types of allergic reactions are associated with Тетрациклин, and what are the warning signs?

Allergic reactions to the drug can range from common skin rashes to more serious hypersensitivity. Warning signs for a serious reaction include swelling of the face, lips, or tongue, hives, trouble swallowing, or sudden dizziness.

Q: Are there specific types of food or drink, other than dairy, that should be avoided?

The key instruction from official administration documents is that the medication must be taken on an empty stomach. Specifically, dairy products must be avoided because they contain mineral cations that significantly interfere with the drug’s absorption. Aside from dairy, no other food or drink is singled out as uniquely problematic beyond the general empty stomach rule.

Advertisements

How should Тетрациклин be stored and disposed of?

Storage and Disposal of Tetracycline

Official Storage Requirements

Tetracycline must be stored at Controlled Room Temperature (CRT), typically between 20 C and 25 C. It is essential to protect the medication from strong sunlight and moisture. To ensure this protection, the product must be kept in its original container and the container must remain tightly closed.

Stability and Safety Constraints

Proper storage conditions are mandatory because the use of deteriorated tetracycline has been associated with reported kidney damage. The medicine must be kept out of the sight and reach of children.

Disposal

All unused medicinal product or waste material must be disposed of in accordance with local requirements for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Тетрациклин found in:

A-Z Index: